Board Recommend Dividend of Rs. 3.50 per equity shares subject to approval of shareholders at ensuing AGM

Revenue declinedProfit growth above 25%Exceptional itemResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.0%Reaction day

₹165.20

prior close

₹155.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-0.3% vs market

Healthcare Service Provider peers, median of 23sector+0.6%-0.6% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.6 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.3

10m

+3.2

15m

+3.2

30m

+6.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.0+0.3-0.3+0.6-0.6

Next day

+2.2+0.7+1.6-0.1+2.4

-3.1+1.0-4.1-0.4-2.8

-2.8+1.1-3.9-0.6-2.3

-1.5+0.8-2.2-0.4-1.0

-3.2+1.3-4.5-0.1-3.1

-3.1+1.7-4.8+0.3-3.4

15d

-2.8+1.5-4.3+2.1-4.9

-5.6+4.0-9.6-0.1-5.4

-6.2+1.8-8.0+8.6-14.8

-12.8-1.0-11.9+11.8-24.6

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved audited standalone results for Q4 and FY ended March 31, 2025, and recommended a final dividend of Rs. 3.50 per equity share (35% on face value of Rs. 10), subject to shareholder approval at the upcoming AGM. Full-year PAT rose sharply to Rs. 773.95 lakh from Rs. 503.37 lakh, and EPS climbed to Rs. 23.10 from Rs. 15.02. However, most of this profit jump came from a one-time Rs. 702.74 lakh gain on sale of investments rather than core business. Net Sales actually dipped about 2% to Rs. 1,654.68 lakh vs Rs. 1,688.23 lakh, and Q4 standalone stood at a loss of Rs. 243.41 lakh. The statutory auditor M.R. Singhwi & Co. issued an unmodified (clean) opinion on the financial results.

Likely market impact

The dividend offers a modest payout to shareholders, but the headline profit growth is largely driven by one-time investment gains, not core operations — underlying business showed weak revenue and a Q4 loss, which investors should weigh before reading too much into the bottom-line jump.